Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study

Author(s):  Santoveña A, Llabrés M, Fariña JB

Issue:  Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue

Abstract:  There were two objectives of this study, one of which was to ensure that different 1-mg/mL hydrocortisone oral suspensions that were prepared as compounded preparations in four accredited laboratories using the same standard operating procedure were in accordance with the general quality controls of these disperse systems and the specific requirements of the European Pharmacopeia, the Royal Spanish Pharmacopeia, and the United States Pharmacopeia. The other objective was to confirm the shelf-life of 90 days that was established for this type of compounded preparation. All the suspensions were in accordance with the organoleptic controls and with the theoretically calculated volume per unit of the preparation, but the amount of active ingredient per volume of the preparations were smaller than the theoretically expected. This result was attributed to the standard operating procedure because no significative differences between laboratories and days were detected, in which an excess of active ingredient is necessary to include in the process to ensure the declared dose. By high-performance liquid chromatography, it was possible to confirm the 90 days of stability of the drug at 5°C.

Related Keywords: A. Santoveña, PhD, M. Llabrés, J.B. Fariña, hydrocortisone oral suspension, formulation, stability

Related Categories: FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, QUALITY CONTROL, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Santoveña A, Llabrés M, Fariña JB Sep/Oct 2010 430-435 Buy
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N Sep/Oct 2003 389-393 Buy
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora Jan/Feb 2001 9 Buy
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard Sep/Oct 2014 427-431 Buy
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D May/Jun 2003 233-239 Buy
Women's Oral Health: Is There a Hormonal Link? Preckshot John Jan/Feb 2004 10 Buy
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Gupta Vishnu D May/Jun 2007 259-261 Buy
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu Mar/Apr 2014 169-174 Buy
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Nahata Milap C Sep/Oct 2015 428-431 Buy
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Trissel Lawrence A, Zhang Yanping, Koontz Susannah E Sep/Oct 2006 396-399 Buy